Who
David J. Mack
Director
Company insider
Files Form 4 as: Director, BioXcel Therapeutics; Director, Terraform Global.
In numbers
- Trades disclosed
- 33
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 4 Jan 2017
- Last trade
- 9 Jan 2026
- Last filed
- 12 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jan 2026filed 12 Jan 2026 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,000 at $0.00 | filing |
| 9 Jan 2026filed 12 Jan 2026 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,000 at $0.00 | filing |
| 31 Oct 2025filed 3 Nov 2025 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,694 at $0.00 | filing |
| 31 Oct 2025filed 3 Nov 2025 | BioXcel TherapeuticsBiotechnology | SEC FORM 4 Code M | —1,694 | filing |
| 30 Sep 2025filed 1 Oct 2025 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,694 at $0.00 | filing |
| 30 Sep 2025filed 1 Oct 2025 | BioXcel TherapeuticsBiotechnology | SEC FORM 4 Code M | —1,694 | filing |
| 31 Aug 2025filed 2 Sep 2025 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,693 at $0.00 | filing |
| 31 Aug 2025filed 2 Sep 2025 | BioXcel TherapeuticsBiotechnology | SEC FORM 4 Code M | —1,693 | filing |
| 31 Jul 2025filed 31 Jul 2025 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,693 at $0.00 | filing |
| 31 Jul 2025filed 31 Jul 2025 | BioXcel TherapeuticsBiotechnology | SEC FORM 4 Code M | —1,693 | filing |
| 30 Jun 2025filed 30 Jun 2025 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,693 at $0.00 | filing |
| 30 Jun 2025filed 30 Jun 2025 | BioXcel TherapeuticsBiotechnology | SEC FORM 4 Code M | —1,693 | filing |
| 31 May 2025filed 2 Jun 2025 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,693 at $0.00 | filing |
| 31 May 2025filed 2 Jun 2025 | BioXcel TherapeuticsBiotechnology | SEC FORM 4 Code M | —1,693 | filing |
| 30 Apr 2025filed 1 May 2025 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,693 at $0.00 | filing |
| 30 Apr 2025filed 1 May 2025 | BioXcel TherapeuticsBiotechnology | SEC FORM 4 Code M | —1,693 | filing |
| 31 Mar 2025filed 1 Apr 2025 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,693 at $0.00 | filing |
| 31 Mar 2025filed 1 Apr 2025 | BioXcel TherapeuticsBiotechnology | SEC FORM 4 Code M | —1,693 | filing |
| 28 Feb 2025filed 4 Mar 2025 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,693 at $0.00 | filing |
| 28 Feb 2025filed 4 Mar 2025 | BioXcel TherapeuticsBiotechnology | SEC FORM 4 Code M | —1,693 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.